Chemoimmunotherapy as a new Strategy in chronic lymphocytic Leukemia German CLL study

被引：0
|
作者：
Peschel, C. [1 ]
Nitschmann, S. [1 ]
机构：
[1] Tech Univ Munich, Med Klin, Klinikum Rechts Isar, D-81675 Munich, Germany
来源：
INTERNIST | 2011年 / 52卷 / 08期
关键词：
FLUDARABINE PLUS CYCLOPHOSPHAMIDE;
D O I：
10.1007/s00108-011-2897-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1011 / 1012
页数：2
相关论文
共 50 条
  • [31] CHROMOSOMAL STUDY OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL)
    FORT, S
    KANTER, RJ
    PHILLIPS, EA
    RAI, KR
    SAWITSKY, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 429 - 429
  • [32] Prognostic Impact of Immunohistochemistry and MRD Results in Bone Marrow after Frontline Chemoimmunotherapy of Chronic Lymphocytic Leukemia (CLL): Results of Central Laboratory Analyses of the CLL10 Trial of the German CLL Study Group (GCLLSG)
    Kutsch, Nadine
    Bottcher, Sebastian
    Robrecht, Sandra
    Bahlo, Jasmin
    Maurer, Christian
    Lange, Elisabeth
    Koppler, Hubert
    Kiehl, Michael G.
    Sokler, Martin
    Schlag, Rudolf
    Vehling-Kaiser, Ursula
    Kochling, Georg
    Ploger, Christoph
    Gregor, Michael
    Plesner, Torben
    Oschlies, Ilske
    Herling, Marco
    Fischer, Kirsten
    Dohner, Hartmut
    Kneba, Michael
    Wendtner, Clemens-Martin
    Kreuzer, Karl-Anton
    Stilgenbauer, Stephan
    Fink, Anna Maria
    Hallek, Michael
    Klapper, Wolfram
    Eichhorst, Barbara F.
    BLOOD, 2017, 130
  • [33] Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
    Shanafelt, T. D.
    Wang, X. V.
    Kay, N. E.
    Hanson, C. A.
    O'Brien, S.
    Barrientos, J.
    Jelinek, D. F.
    Braggio, E.
    Leis, J. F.
    Zhang, C. C.
    Coutre, S. E.
    Barr, P. M.
    Cashen, A. F.
    Mato, A. R.
    Singh, A. K.
    Mullane, M. P.
    Little, R. F.
    Erba, H.
    Stone, R. M.
    Litzow, M.
    Tallman, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (05): : 432 - 443
  • [34] Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
    Goede, Valentin
    Bahlo, Jasmin
    Chataline, Viktoria
    Eichhorst, Barbara
    Duerig, Jan
    Stilgenbauer, Stephan
    Kolb, Gerald
    Honecker, Friedemann
    Wedding, Ulrich
    Hallek, Michael
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 789 - 796
  • [35] Chemoimmunotherapy Improves Survival of Patients with Chronic Lymphocytic Leukemia
    Ghita, Gabriela
    Delgado, Julio
    Baumann, Tycho
    Dlouhy, Ivan
    Aymerich, Marta
    Colomer, Dolors
    Rozman, Maria
    Villamor, Neus
    Creus, Natalia
    Pereira, Arturo
    Montserrat, Emili
    BLOOD, 2011, 118 (21) : 1671 - 1672
  • [36] Treatment of chronic lymphocytic Leukemia in over 80 Years: Experience of the German CLL Study Group (GCLLSG)
    Goede, V.
    Engelke, A.
    Busch, R.
    Hallek, M.
    INTERNIST, 2013, 54 : 127 - 127
  • [37] Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL).
    Wierda, W. G.
    Kipps, T. J.
    Duerig, J.
    Griskevicius, L.
    Stilgenbauer, S.
    Mayer, J.
    Gorczyca, M.
    Andersen, M.
    Nielsen, T.
    Russell, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Ofatumumab-Based Chemoimmunotherapy Is Effective and Well Tolerated in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
    Shanafelt, Tait
    Lanasa, Mark C.
    Call, Timothy G.
    Beaven, Anne W.
    Leis, Jose F.
    LaPlant, Betsy
    Bowen, Deborah
    Conte, Michael
    Jelinek, Diane F.
    Hanson, Curtis A.
    Kay, Neil E.
    Zent, Clive S.
    CANCER, 2013, 119 (21) : 3788 - 3796
  • [39] Relapse treatment of chronic lymphocytic leukemia (CLL)
    Eichhorst, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 266 - 266
  • [40] CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) - TREATMENT
    ROZMAN, C
    MONTSERRAT, E
    BONE MARROW TRANSPLANTATION, 1989, 4 : 159 - 161
12345